Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Suzhou Genhouse Bio Co., Ltd.

Clinical trials sponsored by Suzhou Genhouse Bio Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug cocktail targets Hard-to-Treat cancers Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Not yet recruiting 2 Not yet finished but already full! 1

New drug targets Hard-to-Treat cancers in early trial

Disease control Ongoing

This early-phase study tests a new drug called GH2616 in about 126 people with advanced solid tumors that have not responded to other treatments. The drug works by blocking a protein (KIF18A) that helps cancer cells divide, which may slow or stop tumor growth. The main goals are …

Phase 1 • Sponsor: Suzhou Genhouse Bio Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 08:01 UTC